Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
58pct
2d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · first_quarter · Health Issues
Issues related to drug pricing, drug shortages, drug importation plans, and the drug supply chain, including support for the following bills: Mapping Americas Pharmaceutical Supply (MAPS) Act (H.R. 6992), and the Pediatric Cancer Drug Supply Act of 2024 (H.R. 6963). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction, including support for the following bills: the Fentanyl Safe Testing and Overdose Prevention Act (S. 2569) and the Test Strip Access Act of 2023 (H.R. 4106). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). The Lower Costs, More Transparency Act (H.R. 5378) and the Site-based Invoicing and Transparency Enhancement (SITE) Act (S. 1869), provisions related to site neutral payments. The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153/S. 3679), provisions related to supporting health workers mental health and well-being. Issues related to the Change Healthcare cyberattack, including communications with the Department of Health and Human Services and the Centers for Medicare & Medicaid Services encouraging flexibility following the cyberattack (generally, no specific legislation).
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · fourth_quarter · Health Issues
Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Protecting Patients Against PBM Abuses Act (H.R. 2880), the Transparency and Fairness for Pharmacies Act (H.R. 5393), and the Expanding Seniors Access to Lower Cost Medicines Act of 2023 (H.R. 5372). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction, including support for the following bills: the Fentanyl Safe Testing and Overdose Prevention Act (S. 2569) and the Test Strip Access Act of 2023 (H.R. 4106). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). The Lower Costs, More Transparency Act (H.R. 5378) and the Site-based Invoicing and Transparency Enhancement (SITE) Act (S. 1869), provisions related to site neutral payments. The Safety from Violence for Healthcare Employees Act (H.R. 2584/S. 2768), provisions related to ensuring workplace safety for healthcare workers, including pharmacists.
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · third_quarter · Health Issues
Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), the Pharmacy Benefits Manager Accountability Act (H.R. 2679), and the Promoting Transparency and Healthy Competition in Medicare Act (H.R. 3282). Issues related to COVID-19 response and post-public health emergency recommendations, including telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Issues related to combatting opioid addiction, including support for the following bills: the Fentanyl Safe Testing and Overdose Prevention Act (S. 2569) and the Test Strip Access Act of 2023 (H.R. 4106). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Reauthorization of the Pandemic and All-Hazards Preparedness Act, including recommendations to leverage pharmacists as part of the care team. Patient access to comprehensive reproductive healthcare (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). Issues related to site neutral payments (generally, no specific legislation). The Safety from Violence for Healthcare Employees Act (H.R. 2584/S. 2768), provisions related to ensuring workplace safety for healthcare workers, including pharmacists.
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · second_quarter · Health Issues
H.Res. 436 - Expressing Support for the Designation of the Week of May 22 through26, 2023, as Educator Mental Health Awareness Week" H.R. 498 - 988 Lifeline Cybersecurity Responsibility Act H.R. 734 - Protection of Women and Girls in Sports Act of 2023 H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1114 - Long COVID Recovery Now Act H.R. 1201 - Increasing Behavioral Health Treatment Act H.R. 1202 - REDI Act H.R. 1359 / S. 644 - Modernization of Opioid Treatment Act H.R. 1502 - Comprehensive Opioid Recovery Centers (CORC) Reauthorization Act H.R. 1711 / S. 940 - Rural America Health Corps Act H.R. 1839 - Combating Illicit Xylazine Act H.R. 2389 - Resident Physician Shortage Reduction Act of 2023 H.R. 2400 / S. 1165 - Reentry Act of 2023 H.R. 2412 - Helping Kids Cope Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 2713 - I CAN Act H.R. 3073 / S. 1452 - Community Mental Wellness and Resilience Act of 2023 H.R. 3074 / S. 971 - Due Process Continuity of Care Act H.R. 3150 / S. 983 - OPIOIDS Act H.R. 3305 / S. 1606 - Black Maternal Health Momnibus Act H.R. 3548 / S. 1700 Pursuing Equity in Mental Health Act H.R. 3713 / S. 1884 Mental Health Services for Students Act H.R.3570 - Comprehensive Response to Fentanyl-Related Substances and Fentanyl-laced Substances Act H.R.3680 - Stop Mental Health Stigma in Our Communities Act H.R. 3736 - Extending Access to Addiction Treatment Act H.R. 3752 - Parity Enforcement Act of 2023 H.R. 3836 - Medicaid Primary Care Improvement Act H.R. 3838 - Preventing Maternal Deaths Reauthorization Act H.R. 3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs. H.R. 3887 - Childrens Hospital GME Support Reauthorization Act of 2023 H.R. 3892 - Improving Mental Health and Drug Treatment Act H.R. 4007 - HEAL Act H.R. 4053 - Studying Suboxone Act H.R. 4054 - Trauma Support and Mental Health in Schools Reauthorization Act H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023 H.R. 4057 - Keeping Kids Safe Act H.R. 4063 - FIND Fentanyl Act of 2023 H.R. 4079 - Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023 H.R. 4080 - Trauma-Informed Care Task Force Reauthorization Act of 2023 H.R. 4088 - CAREER Act H.R. 4089 - Safer Response Act H.R. 4091 - Combatting Substance Use Disorder Act H.R. 4092 - Protecting Moms and Infants Reauthorization Act H.R. 4093 - Remote Opioid Monitoring Act of 2023 H.R. 4095 - Save Children from Trauma Act H.R. 4096 - A bill to amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries H.R. 4097 - Mental Health Improvement Act H.R. 4098 - Communities of Recovery Reauthorization Act H.R. 4099 - RECONNECTS Act of 2023 H.R. 4100 - To amend the Public Health Service Act to reauthorize a monitoring and education program regarding infections associated with illicit drug use and other risk factors H.R. 4101 - Road to Recovery Act H.R. 4106 - To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips H.R. 4189 / S. 2016 - CONNECT for Health Act S. 462 - Mental Health Professionals Workforce Shortage Loan Repayment Act S. 665 - Conrad State 30 and Physician Access Reauthorization Act S. 669 - Increasing Mental Health Options Act of 2023 S. 923 - Better Mental Health Care for Americans Act S.1378 - Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act S. 1426 - RISE from Trauma Act
Client expense: $193,806 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE